Warning: include(phj2-admin/kernel/config.php): failed to open stream: No such file or directory in /zstorage3/vhosts/fz.kiev.ua/httpdocs/index.php on line 45

Warning: include(): Failed opening 'phj2-admin/kernel/config.php' for inclusion (include_path='.:/usr/local/share/pear') in /zstorage3/vhosts/fz.kiev.ua/httpdocs/index.php on line 45

Warning: Cannot modify header information - headers already sent by (output started at /zstorage3/vhosts/fz.kiev.ua/httpdocs/index.php:45) in /zstorage3/vhosts/fz.kiev.ua/httpdocs/kernel/content.php on line 3

Warning: array_unique() expects parameter 1 to be array, null given in /zstorage3/vhosts/fz.kiev.ua/httpdocs/kernel/content.php on line 77

Warning: Invalid argument supplied for foreach() in /zstorage3/vhosts/fz.kiev.ua/httpdocs/kernel/content.php on line 86
Fiziologichnyi Zhurnal - <a id="lj1_ret_bk_to_jl0_href_id" href="?list0=11">Fiziol. Zh. 2009;</a> <a id="lj1_ret_bk_to_jl0_href_id" href="?list1=52">55(1):</a> 43-48
Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2009; 55(1): 43-48


The influence of introduction of proteinase inhibitorson efficiency for suppression of proteolytic activation of pneumonia

A.V. Kubyshkin, I.I. Fomochkina.

    The Crimea State Medical University , Simferopol,Ukraine


Abstract

We studied the influence of a way of introduction proteinase inhibitors on efficiency of suppression of proteolysis activation during pneumonia. Comparative study of efficiency of proteases inhibition in experimental pneumonia has shown higher efficacy of local introduction of drugs. Intravenous and intraperitoneal introduction of proteinase inhibitors exhibited inhibitory effect of a smaller degree on local and systemic proteases activation, did not decrease an acute phase of response of a-1-protease inhibitor in comparison with endotracheal instillation of Contrycal and Ingiprol. The study has established that endotracheal intro­duction of proteinase inhibitors is the most effective for correction of the proteinase-inhibitor balance. It also helps to promote the activity proteinase-inhibitor, suppresses elastolytic activity, de­creases cellular infiltration, reduces the concentration of pro­teins in bronco-alveolar lavage fluid that is connected with ad­dress delivery of drugs to the target organ creating a maximal concentration of drugs in affected area.

References

  1. Захарьевская М.А., Аничков Н.Н. Об изменении легочной ткани при введении инородного тела в бронх // Бюл. эксперим. биологии и медицины. - 1952. -№ 6. - С. 62-67.
  2. Кринская А.В., Пасхина Т.С. Количественное определение калликреина и калликреиногена в сыворотке (плазме) крови человека // Совр. методы биохимии. -М.: Медицина, 1977. - C. 163-170.
  3. Кубышкин А.В., Донецкий И.А., Балабушевич Н.Г., Макаревич И.А. Сравнительное изучение нового панкреатического ингибитора протеиназ при инициа-ции воспаления в легких // Хим.-фарм. журн. - 1993. -№3. -С. 17-19.
  4. Нартикова В.Ф., Пасхина Т.С. Унифицированный метод определения активности a1-антитрипсина и a-макроглобулина в сыворотке (плазме) крови человека // Вопр. мед. химии. - 1979. - № 4. - C. 494-499.
  5. Оглоблина О.Г., Платонова Л.В., Мясникова Л.В. и др. Активность протеиназ гранулоцитов и уровень кислотостабильных ингибиторов протеназ в бронхо-альвеолярном секрете детей с бронхопатиями различной этиологии // Там же. - 1980. - № 3. -C. 387-392.
  6. Семенкова Г.Г., Сильвестров В.П., Провоторов В.М. Немедленные и отдаленные результаты лечения пациентов с неспецифическимим заболеваниями легких посредством местного примененеия контри-кала и антибиотиков // Терап. архив. - 1992. - 64, №3. -С. 66-71.7. Тинни Д. Введение в теорию планирования экспе-риментов. - М.: Наука, 1970. - С. 33.
  7. Шульпекова Ю.О. Апротинин - важный компонент терапии критических состояний // Рус. мед. журн. -2000. - 8, №7. -С. 296-299.
  8. 9. Douvas S., Kolokotronis A., Stefanopoulos P. Anti-Inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor // Inf. and Immunol. - 2005. -73, №3. - P. 1271-1274.
  9. 10. Griese M., Latzin P., Kappler M. et al. Alpha1-Antit-rypsin inhalation reduces airway inflammation in cystic fibrosis patients // Eur. Respir. J. - 2007. - 29, № 2. -P. 240-250.
  10. Hook V. Y, Hwang S.R. Novel secretory vesicle serpins, endopin 1 and endopin 2: endogenous protease inhibi­tors with distinct target protease specificities // Biol. Chem. - 2002. - 383, № 7-8. - P. 1067-1074.
  11. Lowry O., Rosenbrough U., Farr A., Roundal R. Pro­tein measurement with the Folin phenol reagent // J. Biol. Chem. - 1951. - 193, № 1. - P. 265-275.
  12. Okumura Y, Ogawa K., Uchiya K. Characterization and primary structure of elastase inhibitor, AFLEI, from Aspergillus flavus // Nippon. Ishinkin. Gakkai. Zasshi. -2007. - 48, № 1. -P. 13-18.
  13. Ovcharenko A.V., Zhirnov O.P. Aprotinin aerosol treat­ment of influenza and paramyxovirus bronchopneumo­nia of mice // Antiviral. Res. - 1994. - 23, № 2. -P. 107-118.
  14. Vender R.L. Therapeutic potential of neutrophil-elastase inhibition in pulmonary disease // J. Invest. Med. - 1996. -44. - P. 531-539.
  15. Wei S., Chen Y, Chung L. et al. Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) in­hibitory domain. In search of selective matrix metalloproteinase inhibitors // J. Biol. Chem. - 2003. -278, № 11. -P. 9831-9834.
  16. Zheng C.J., Han L.Y, Yap C.W. et al. Therapeutic tar­gets: progress of their exploration and investigation of their characteristics // Pharmacol. Rev. - 2006. - 58, № 2. - P. 259-279.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.